Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:38 PM
Ignite Modification Date:
2025-12-24 @ 11:38 PM
NCT ID:
NCT01897051
Eligibility Criteria:
Inclusion Criteria:
* Liver cirrhosis:diagnosed based on histology or unequivocal clinical, sonographic, and laboratory findings
* 19≤age≤75
* Hepatic venous pressure gradient \> 12 mmHg
* Informed consent
Exclusion Criteria:
* Shock status requiring vasopressor
* Active infection, for example Spontaneous bacterial peritonitis
* Acute renal failure patients of any cause
* Clinically relevant coronary artery disease(NYHA functional angina classification III/IV),congestive heart failure NYHA III/IV), clinically relevant cardiomyopathy, history of myocardial infarction in the past 12 months
* Poorly controlled hypertension (BP 150/100mmHg)
* Hepatocellular carcinoma
* History of another primary malignancy ≤ 3years
* Medical or psychological conditions that would not permit the subject to complete thte study or sign informed consent
* Pregnancy or lactation period
* Serum creatinine ≧ 6mg/dL
* Involvement in the conduct of other study within 30 days
* Known hypersensitivity to Rifaximin or propranolol
* Dysarrhythmia, inappropriate for study on investigator's judgment
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Maximum Age:
75 Years
Study:
NCT01897051
Study Brief:
Protocol Section:
NCT01897051